AngioDynamics (ANGO) Competitors $6.80 +0.06 (+0.89%) (As of 10:25 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ANGO vs. ANIK, SPNE, CTSO, OFIX, SRDX, ARAY, RMTI, RSLS, ABT, and ISRGShould you be buying AngioDynamics stock or one of its competitors? The main competitors of AngioDynamics include Anika Therapeutics (ANIK), SeaSpine (SPNE), Cytosorbents (CTSO), Orthofix Medical (OFIX), Surmodics (SRDX), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "medical" sector. AngioDynamics vs. Anika Therapeutics SeaSpine Cytosorbents Orthofix Medical Surmodics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical AngioDynamics (NASDAQ:ANGO) and Anika Therapeutics (NASDAQ:ANIK) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, community ranking, media sentiment, risk, dividends and valuation. Does the media refer more to ANGO or ANIK? In the previous week, AngioDynamics had 4 more articles in the media than Anika Therapeutics. MarketBeat recorded 4 mentions for AngioDynamics and 0 mentions for Anika Therapeutics. AngioDynamics' average media sentiment score of 1.08 beat Anika Therapeutics' score of 0.00 indicating that AngioDynamics is being referred to more favorably in the media. Company Overall Sentiment AngioDynamics Positive Anika Therapeutics Neutral Is ANGO or ANIK more profitable? Anika Therapeutics has a net margin of -59.40% compared to AngioDynamics' net margin of -83.95%. Anika Therapeutics' return on equity of -2.22% beat AngioDynamics' return on equity.Company Net Margins Return on Equity Return on Assets AngioDynamics-83.95% -5.86% -4.17% Anika Therapeutics -59.40%-2.22%-1.75% Which has more risk & volatility, ANGO or ANIK? AngioDynamics has a beta of 0.67, meaning that its stock price is 33% less volatile than the S&P 500. Comparatively, Anika Therapeutics has a beta of 0.86, meaning that its stock price is 14% less volatile than the S&P 500. Does the MarketBeat Community favor ANGO or ANIK? AngioDynamics received 64 more outperform votes than Anika Therapeutics when rated by MarketBeat users. However, 64.33% of users gave Anika Therapeutics an outperform vote while only 61.06% of users gave AngioDynamics an outperform vote. CompanyUnderperformOutperformAngioDynamicsOutperform Votes36761.06% Underperform Votes23438.94% Anika TherapeuticsOutperform Votes30364.33% Underperform Votes16835.67% Which has preferable valuation and earnings, ANGO or ANIK? Anika Therapeutics has lower revenue, but higher earnings than AngioDynamics. Anika Therapeutics is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAngioDynamics$303.91M0.91-$184.35M-$6.09-1.12Anika Therapeutics$166.66M1.50-$82.67M-$6.65-2.56 Do insiders & institutionals have more ownership in ANGO or ANIK? 89.4% of AngioDynamics shares are owned by institutional investors. Comparatively, 91.5% of Anika Therapeutics shares are owned by institutional investors. 5.4% of AngioDynamics shares are owned by company insiders. Comparatively, 7.9% of Anika Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts recommend ANGO or ANIK? AngioDynamics currently has a consensus target price of $12.00, indicating a potential upside of 76.47%. Anika Therapeutics has a consensus target price of $24.50, indicating a potential upside of 43.70%. Given AngioDynamics' stronger consensus rating and higher probable upside, equities analysts plainly believe AngioDynamics is more favorable than Anika Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AngioDynamics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Anika Therapeutics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryAngioDynamics and Anika Therapeutics tied by winning 9 of the 18 factors compared between the two stocks. Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANGO vs. The Competition Export to ExcelMetricAngioDynamicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$276.28M$4.43B$5.07B$8.80BDividend YieldN/A36.79%4.99%4.07%P/E Ratio-1.1213.5789.5613.60Price / Sales0.9144.221,224.8087.40Price / Cash1.5752.2739.4536.27Price / Book1.335.776.976.33Net Income-$184.35M$13.76M$119.04M$225.93M7 Day Performance-0.73%-0.99%-1.78%-0.96%1 Month Performance3.98%0.71%-3.59%1.06%1 Year Performance0.59%51.46%31.64%26.59% AngioDynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANGOAngioDynamics4.7632 of 5 stars$6.80+0.9%$12.00+76.5%-1.9%$276.28M$303.91M-1.12748Positive NewsANIKAnika Therapeutics2.8685 of 5 stars$17.05-0.8%$24.50+43.7%-16.6%$249.78M$166.66M-2.58357SPNESeaSpineN/A$9.54flatN/A+0.0%$354.92M$191.45M-5.39523Gap DownCTSOCytosorbents1.2769 of 5 stars$0.95+3.7%$2.00+110.5%-34.6%$51.95M$36.35M0.00186Analyst ForecastOFIXOrthofix Medical1.3806 of 5 stars$18.91+0.2%$23.00+21.6%+74.4%$722.55M$746.64M0.001,634SRDXSurmodics4.2188 of 5 stars$39.17flat$50.00+27.6%+12.2%$558.96M$126.08M0.00376ARAYAccuray4.6915 of 5 stars$1.88+2.5%$9.00+380.0%-32.5%$188.57M$446.55M0.00987Analyst RevisionRMTIRockwell Medical4.2639 of 5 stars$2.27-2.6%$7.00+208.4%+19.5%$73.37M$83.61M-46.60300Analyst DowngradeRSLSReShape Lifesciences0.1279 of 5 stars$4.98-1.2%N/A-62.2%$3.54M$8.68M0.0050Gap UpABTAbbott Laboratories4.9711 of 5 stars$116.08+0.1%$130.07+12.0%+14.6%$201.33B$40.11B35.24114,000Positive NewsISRGIntuitive Surgical4.6512 of 5 stars$544.56+0.5%$524.61-3.7%+74.0%$193.96B$7.12B87.1113,676Analyst UpgradePositive News Related Companies and Tools Related Companies Anika Therapeutics Competitors SeaSpine Competitors Cytosorbents Competitors Orthofix Medical Competitors Surmodics Competitors Accuray Competitors Rockwell Medical Competitors ReShape Lifesciences Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ANGO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
